具代表性研究發表

搜尋類別: 關鍵字搜尋: 清除
年度 論文名稱
2025 Huang YT, Hsu YC, (Yang HI, Lee MH, Lai TS, Chen CJ, Huang YT, Corrigendum: "Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study" [J Epidemiol 35(1) (2025) 21-29]., JOURNAL OF EPIDEMIOLOGY, vol. doi: 10.2188/jea.JE20250177., Online ahead of print., 2025
2025 Li TH, Huang YS, Ma CC, Tsai SY, Tsai HC, Yeh HY, Shen HC, Hong SY, Su CW, (Yang HI*, Yang YY*, Hou MC, GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia., KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025
2025 Li H, Chiang CL, Kwak KJ, Lee HL, Wang X, Romano G, Saviana M, Toft R, Cheng TS, Chang Y, Hsiang BD, Liu GW, Mo X, Ma Y, Pan J, Rima XY, Kim TN, Reategui E, (Shen CN, Chu YS, Croce C, Chang PM, Yeh YC, Carbone DP, Huang CF, Chiang CL, Nana-Sinkam P, Lee LJ, Extracellular Vesicular Delta-Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis., Advanced Science, vol. doi: 10.1002/advs.202416711., Online ahead of prin, 2025
2025 Lee C.Y., T.C. Kuo, Y.H. Chou, S.J. Peng, F.T. Hsiao, M.H. Chung, L.W. Lo, (C.N. Shen, H.J. Chien, H.P. Chang, C. C. Chen, Y.M. Jeng, Y.W. Tien, S.C. Tang., Human pancreatic duct-β-cell cluster in microscopic cystic change: panoramic-to-3D/cytokeratin and vesicle imaging, Diabetes, vol. 74(5), 734-748, 2025
2025 Lo JM., Kung CC, Cheng TJR, Wong CH*, (Ma C*, Structure-Based Mechanism and Specificity of Human Galactosyltransferase β3GalT5, Journal of the American Chemical Society, vol. 147(13), 10875-10885, 2025
2025 Kung CC, Lo JM., Liao KS, Wu CY, Cheng LC, Chung C, Hsu TL, (Ma C)*, Wong CH*, Expression of Human β3GalT5–1 in Insect Cells as Active Glycoforms for the Efficient Synthesis of Cancer-Associated Globo-Series Glycans, Journal of the American Chemical Society, vol. 147(13), 10864-10874, 2025
2025 Liu, P.-C., Huang, S.-Y., (Lin, K.-I, Hsieh, S.-L, Leu, C.-M., Suppression of NF-κB and downstream XBP1 by DcR3 contributes to a decrease in antibody secretion, JOURNAL OF IMMUNOLOGY, vol. 214, 72-84, 2025
2025 Enkhbayar, B., Lu, S.-C., Tsai, H.-Y., Liang, S.-Y., Wu, S.-J., (Lin, K.-I, Angata, T., Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia., Journal of Biological Chemistry, vol. 108386, 108386, 2025
2025 Y. L. Chan, J. C. Liao, T. L. Li, C. J. Wu*, Y. H. Chiu*, Bifidobacterium lactis ameliorates AOM/DSS‑induced inflammation, dysbiosis, and colonic precancerous lesions, APPLIED MICROBIAL AND CELL PHYSIOLOGY, vol. 109 (69), 1-15, 2025
2025 H. T. Huang, C. T. Chiou, Y. C. Lin, L. J. Zhang, C. H. Chao, P. J. Sung, J. J. Chen, T. L. Li, I. W. Lo*, C. C. Liaw*, Potential Anti-H1N1 Schtriterpenoids from Kadsura japonica L. Vines, PHYTOCHEMISTRY, vol. 240, 114632, 2025
2025 Hu CM*, Tien SC, Lo YC, Huang CH, Ko YL, Wu DN, Lee JH, Wu YT, Yu HM, Ling KG, Lee ZY, Cheng WC, Novel cyclic peptide disrupts the IL-17RB/MLK4 interaction for targeted therapy of pancreatic cancer, Biomedicine & Pharmacotherapy, vol. 184, 117892, 2025
2025 Tien SC, Shih M, Hu CM*, Inhibition of RRM1 O-GlcNAcylation suppresses pancreatic cancer via TK1 stabilization-induced replication stress, Cancer Gene Therapy, 2025
2025 Gary Jen-Wei Chen§, Ming-Yun Chang§, Xin-Peng Lin, Debapriya Kundu, Yu-Jen Chang, Yun-Ru Chen)*, Tau destabilization in a familial deletion mutant K280 accelerates its fibrillization and enhances the seeding effect, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 301(2), 108184, 2025
2025 Hsiang-Ting Lee, Han-Wen Chang, Yeh-Tung Lin, Shing- Jong Huang, Meng-Hsin Wu, Chang-Shun Tsai, Ling-Hsien Tu, Ming-Che Lee, (Yun-Ru Chen)*, Jerry C. C. Chan*, Oligomeric Protein Complexes formed by Beta Amyloid Peptides and Their Molecular Associates, CHEMISTRY-A EUROPEAN JOURNAL, 2025
2025 Chia-Yi Ho, Yu-Jen Chang, Chih-Wen Yang, Orion Shih, U-Ser Jeng, Wan-Chen Huang, Ing-Shouh Hwang, (Yun-Ru Chen)*, Membrane disruption properties of poly-glycine arginine dipeptide repeats affected by peptide repeats continuity and membrane composition, Journal of Molecular Biology, 2025
2025 Zhuoming Zhou, Wei Chen*, Yihai Cao, Reza Abdi, Wei Tao*, Nanomedicine-based Strategies for the Treatment of Vein Graft Disease, Nature Reviews Cardiology, vol. 22, 255-272, 2025
2025 Shuying Chen†, Yongjiang Li†, Zhuoming Zhou, Qimanguli Saiding, Yiming Zhang, Soohwan An, Muhammad Muzamil Khan, Xiaoyuan Ji, Ruirui Qiao, Wei Tao*, Na Kong*, Wei Chen*, Tian Xie*, Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy, Science Advances, vol. 11, eadw7191, 2025
2025 H. T. Huanga, C. T. Chioua, Y. C. Lin, L. J. Zhang, C. H. Chao, P. J. Sung, J. J. Chen, T. L. Li, I. W. Lo*, C. C. Liaw*, Potential Anti-H1N1 Schtriterpenoids from Kadsura japonica L. Vines, PHYTOCHEMISTRY, 2025
2025 Y. L. Chan, J. C. Liao, T. L. Li, C. J. Wu*, Y. H. Chiu*, Bifidobacterium lactis ameliorates AOM/DSS‑induced inflammation, dysbiosis, and colonic precancerous lesions, APPLIED MICROBIAL AND CELL PHYSIOLOGY, vol. 109 (69), 1-15, 2025
2025 Li TH, Huang YS, Ma CC, Tsai SY, Tsai HC, Yeh HY, Shen HC, Hong SY, Su CW, (Yang HI*, Yang YY*, Hou MC, GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia., KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025
2025 Huang YT, Hsu YC, (Yang HI, Lee MH, Lai TS, Chen CJ, Huang YT, Corrigendum: "Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study" [J Epidemiol 35(1) (2025) 21-29]., JOURNAL OF EPIDEMIOLOGY, vol. doi: 10.2188/jea.JE20250177., Online ahead of print., 2025
2025 Tseng TC, Huang SC, Pan MH, Liu CJ, Chen CJ, Yang WT, Tsai CH, Su TH, Yang HC, Liu CH, Chen PJ, (Yang HI*, Kao JH*, Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold., GUT, 2025
2025 Tseng TC, Hosaka T, Pan MH, Liu CJ, Suzuki F, Chen CJ, Su TH, Kumada H, Yang WT, Yang HC, Liu CH, Chen PJ, (Yang HI*, Kao JH*, Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patients., HEPATOLOGY, vol. doi: 10.1097/HEP.0000000000001313, Online ahead of prin, 2025
2025 Zhang T, Huang CJ, Chen HT, Huang YH, Pan MH, Lee MH, Viard M, Hildesheim A, Pfeiffer RM, Carrington M, Chen CJ, Zhu B, Lenz TL, Jiang D*, (Yang HI*, Liu Z, HLA-DQB1*03:01 and risk of Hepatitis B virus-related hepatocellular carcinoma., HEPATOLOGY, vol. doi: 10.1097/HEP.0000000000001307, Online ahead of print, 2025
2025 Chen CL, Yang WS, (Yang HI, Chen CF, Wang LY, Lu SN, Kao JH, Chen PJ, Chen CJ, Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study., LIVER CANCER, vol. 14(1), 19-35, 2025
2024 Cheung EC, Strathdee D, Stevenson D, Coomes J, Blyth K, Vousden KH, Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment., Proceedings of the National Academy of Sciences of the United States of America, vol. 121(50), e2416076121, 2024
2024 Furuya H, Nguyen CT, Chan T, Marusina AI, Merleev AA, Garcia-Hernandez ML, (Hsieh SL, Tsokos GC, Ritchlin CT, Tagkopoulos I, Maverakis E, Adamopoulos IE*, IL-23 induces CLEC5A(+) IL-17A(+) neutrophils and elicit skin inflammation associated with psoriatic arthritis., Journal of autoimmunity, vol. 143, 103167, 2024
2024 Furuya H, Nguyen CT, Chan T, Marusina AI, Merleev AA, Garcia-Hernandez ML, (Hsieh SL, Tsokos GC, Ritchlin CT, Tagkopoulos I, Maverakis E, Adamopoulos IE*, IL-23 induces CLEC5A(+) IL-17A(+) neutrophils and elicit skin inflammation associated with psoriatic arthritis., Journal of autoimmunity, vol. 143, 103167, 2024
2024 Chang CM, Chang WC*, (Hsieh SL)*, Characterization of the genetic variation and evolutionary divergence of the CLEC18 family., Journal of biomedical science, vol. 31(1), 53, 2024
2024 Tsui KH, Liu CL, Yeh HL, Liu MK, Li CH, Chen WH, Jiang KC, Li HR, Thuy Dung PV, (Hsiao M, Abou-Kheir W, (Liu YN, WNT1-inducible signaling pathway protein 1 activation through C-X-C motif chemokine ligand 5/C-X-C chemokine receptor type 2/leukemia inhibitory factor/leukemia inhibitory factor receptor signaling promotes immunosuppression and neuroendocrine differentiation in prostate cancer., iScience, vol. 27(8), 110562, 2024